Quantitative Systematic Strategies LLC Iveric Bio, Inc. Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$7.07 - $17.5 $85,398 - $211,382	-12,079 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$5.69 - $7.17 $126,562 - $159,482	-22,243 Reduced 64.81%	12,079 $76,000
Q1 2021 May 06, 2021	SELL	$5.08 - $6.89 $63,616 - $86,283	-12,523 Reduced 26.73%	34,322 $212,000
Q4 2020 Feb 09, 2021	BUY	$5.65 - $7.66 $71,201 - $96,531	12,602 Added 36.8%	46,845 $324,000
Q3 2020 Nov 09, 2020	BUY	$4.01 - $6.29 $12,218 - $19,165	3,047 Added 9.77%	34,243 $193,000
Q2 2020 Aug 04, 2020	BUY	$3.06 - $6.6 $39,672 - $85,569	12,965 Added 71.12%	31,196 $159,000
Q1 2020 May 06, 2020	BUY	$2.83 - $8.44 $51,593 - $153,869	18,231 New	18,231 $63,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.